Decheng Capital

Summary

Decheng Capital is the famous VC, which was founded in 2011. The venture was found in Asia in China. The main office of represented VC is situated in the Shanghai.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Decheng Capital, startups are often financed by Sofinnova Investments, Lilly Asia Ventures, Kleiner Perkins. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, OrbiMed, Celgene. In the next rounds fund is usually obtained by XSeed Capital, Wooshin Venture Investment Corp., South China Venture Capital.

Among the most popular portfolio startups of the fund, we may highlight luckin coffee, ARMO BioSciences, Mindstrong Health. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Biopharma. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.

Comparing to the other companies, this Decheng Capital performs on 10 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2018. The real fund results show that this VC is 28 percentage points more often commits exit comparing to other companies. The typical startup value when the investment from Decheng Capital is more than 1 billion dollars. The top amount of exits for fund were in 2019. The fund is generally included in 2-6 deals every year.

The overall number of key employees were 3.